Tüdőrák: nyitott vizsgálatok itt: Puerto Rico

• NCT05920356

  A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  Kísérleti kezelés · 3. fázis · Amgen

  Pan American Center for Oncology Trials, Ponce

  Regiszter frissítve: 2026-11-06

• NCT06881784

  Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  Kísérleti kezelés · 3. fázis · Revolution Medicines, Inc.

  Pan American Center for Oncology Trials, San Juan

  Regiszter frissítve: 2026-11-06

• NCT07659782

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

  Kísérleti kezelés · 2. fázis · Verastem, Inc.

  BRCR Global- San Juan, San Juan · BRCR Global- Yauco, Yauco

  Regiszter frissítve: 2026-11-06

• NCT07090499

  A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  Kísérleti kezelés · 1. fázis · Pfizer

  Pan American Center for Oncology Trials LLC, Rio Piedras

  Regiszter frissítve: 2026-11-05

• NCT07144280

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  Kísérleti kezelés · 3. fázis · Pfizer

  Ad-Vance Medical Research, Ponce

  Regiszter frissítve: 2026-11-05

• NCT07519655

  Phase 1 Study of PF-08046033 in Advanced Solid Tumors

  Kísérleti kezelés · 1. fázis · Pfizer

  Hospital Oncologico Dr. Isaac Gonzalez-Martinez, Rio Piedras · Pan American Center for Oncology Trials LLC, Rio Piedras

  Regiszter frissítve: 2026-11-05

• NCT03556228

  VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  Kísérleti kezelés · 1/2. fázis · VM Oncology, LLC

  PanOncology Trials, Hospital Oncologico - Puerto Rico Medical Center, Río Piedras (site 200), San Juan

  Regiszter frissítve: 2026-11-04

• NCT06418204

  Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  Kutatás · Wake Forest University Health Sciences

  Doctors Cancer Center, Manati · Centro Comprensivo de Cancer de UPR, San Juan · PROncology, San Juan

  Regiszter frissítve: 2026-11-04

• NCT06667076

  A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  Kísérleti kezelés · 2. fázis · Janssen Research & Development, LLC

  Auxilio Mutuo Cancer Center, San Juan

  Regiszter frissítve: 2026-11-03

• NCT06692738

  A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

  Kísérleti kezelés · 3. fázis · AstraZeneca

  San Juan

  Regiszter frissítve: 2026-10-29

• NCT06357533

  Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

  Kísérleti kezelés · 3. fázis · AstraZeneca

  San Juan

  Regiszter frissítve: 2026-10-28

• NCT06627647

  A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

  Kísérleti kezelés · 3. fázis · AstraZeneca

  San Juan

  Regiszter frissítve: 2026-10-28

• NCT07109726

  A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  Kísérleti kezelés · 1/2. fázis · Terremoto Biosciences Inc.

  PanOncology Trials, San Juan

  Regiszter frissítve: 2026-10-28

• NCT06772623

  Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

  Kísérleti kezelés · 1/2. fázis · AbbVie

  Pan American Center for Oncology Trials - Rio Piedras /ID# 268827, Rio Piedras

  Regiszter frissítve: 2026-10-27

• NCT07756645

  A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult Participants

  Kísérleti kezelés · 3. fázis · AbbVie

  Pan American Center for Oncology Trials - Rio Piedras /ID# 284017, Rio Piedras

  Regiszter frissítve: 2026-10-20

• NCT07222566

  Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  Kísérleti kezelés · 3. fázis · Pfizer

  Pan American Center for Oncology Trials, LLC - Bayamón Office, Bayamón · Pan American Center for Oncology Trials, LLC- Dorado Office, Dorado · Pan American Center for Oncology Trials, LLC - Manati Office, Manati · Pan American Center for Oncology Trials, LLC - Mayaguez Office, Mayagüez · BRCR Global Puerto Rico - Hato Rey, San Juan

  Regiszter frissítve: 2026-10-08

• NCT07226999

  Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

  Kísérleti kezelés · 2/3. fázis · Pfizer

  Doctor's Center Hematology & Oncology Group, Manati · Pan American Center for Oncology Trials, LLC - Mayaguez Office Mayaguez Medical Center, Mayagüez · Pan American Center for Oncology Trials LLC, San Juan · Hospital Oncologico Dr. Isaac Gonzalez-Martinez, San Juan

  Regiszter frissítve: 2026-10-08

• NCT07227298

  Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

  Kísérleti kezelés · 1/2. fázis · Pfizer

  Pan American Center for Oncology Trials, LLC - Mayaguez, Mayagüez · Pan American Center for Oncology Trials LLC, Rio Piedras · BRCR Global Puerto Rico - Hato Rey, San Juan

  Regiszter frissítve: 2026-10-08

• NCT07489066

  Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

  Kísérleti kezelés · 2. fázis · Pfizer

  Pan American Center for Oncology Trials, LLC - Bayamón Office, Bayamón · Pan American Center for Oncology Trials, LLC - Manati Office, Manati · Pan American Center for Oncology Trials, LLC - Ponce Office, Ponce · Hospital Oncologico Dr. Isaac Gonzalez-Martinez, Rio Piedras · Pan American Center for Oncology Trials, LLC - Ciudadela Office, San Juan

  Regiszter frissítve: 2026-10-08

• NCT06128551

  Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  Kísérleti kezelés · 1/2. fázis · Revolution Medicines, Inc.

  Pan American Center for Oncology Trials, San Juan

  Regiszter frissítve: 2026-09-22

• NCT06858813

  A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

  Kísérleti kezelés · 1. fázis · AbbVie

  Fdi Clinical Research /ID# 272960, San Juan

  Regiszter frissítve: 2026-09-22

• NCT06427941

  A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

  Kísérleti kezelés · 1/2. fázis · BeOne Medicines

  Hospital Oncologico, Rio Piedras

  Regiszter frissítve: 2026-09-16

• NCT05150691

  A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

  Kísérleti kezelés · 1/2. fázis · DualityBio Inc.

  BRCR Global Puerto Rico LLC., Mayagüez

  Regiszter frissítve: 2026-08-27

• NCT06350097

  Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

  Kísérleti kezelés · 3. fázis · AstraZeneca

  Rio Piedras · San Juan

  Regiszter frissítve: 2026-08-26

• NCT05235165

  Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

  Kísérleti kezelés · 3. fázis · Children's Oncology Group

  HIMA San Pablo Oncologic Hospital, Caguas

  Regiszter frissítve: 2026-08-25

Minden vizsgálat (Tüdőrák) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek